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A B S T R A C T
Chemoradiation is an established approach in the treatment of advanced oral tongue squamous cell carcinoma
(OTSCC), but therapy may cause severe side-eﬀects due to signal interchanges between carcinoma and the
tumour microenvironment (TME). In this study, we examined the potential use of our human 3D myoma disc
and Myogel models in in vitro chemoradiation studies by analysing the eﬀects of ionizing radiation (IR) and the
combined eﬀect of heparanase I (HPSE1) inhibitors and IR on OTSCC cell proliferation, invasion and MMP-2 and
− 9 production. Finally, we analysed the long-term eﬀects of IR by studying clones of previously irradiated and
invaded HSC-3 cells. We found that in both human uterine leiomyoma-based extracellular matrix models IR
inhibited the invasion of HSC-3 cells, but blocking HPSE1 activity combined with IR induced their invasion. Low
doses of IR increased MMP expression and initiated epithelial-mesenchymal transition in cells cultured on
myoma discs. We conclude that myoma models oﬀer consistent methods for testing human carcinoma cell in-
vasion and phenotypic changes during chemoradiation treatment. In addition, we showed that IR had long-term
eﬀects on MMP-2 and − 9, which might elicit diﬀerent HSC-3 invasion responses when cells were under the
challenge of HPSE1 inhibitors and IR.
1. Introduction
Squamous cell carcinoma (SCC) is the most common cancer in the
oral cavity [1], and most of the tumours occur along the lateral borders
of the oral tongue (OT) [2,3]. Despite advances in diagnostics and
therapeutics, the survival rate of oral tongue squamous cell carcinoma
(OTSCC) has improved by only 5% in the past 20 years, and in general
the 5‐year survival rate remains around 60% [4].
Treatment approaches for tongue cancer include surgery, in ad-
vanced stages combined with radiotherapy and sometimes che-
motherapy. Although radiotherapy has proven its beneﬁt in several
clinical studies, some patients develop local recurrences and metastases
after the treatment. In vitro studies have shown that ionizing radiation
(IR) increases cell migration and/or invasion due to increased expres-
sion of pro-migratory factors and the epithelial-mesenchymal transition
(EMT) of cancer cells. Furthermore, cells in the irradiated tumour mi-
croenvironment (TME) may support the invasiveness of cancer cells
[5,6]. OTSCC is often refractory and there are only a few drugs for the
treatment of advanced cancer. Currently, an established standard for
ﬁrst-line treatment of recurrent metastatic head and neck squamous cell
carcinomas (HNSCCs), including OTSCC, is a combination of cisplatin/
carboplatin, 5-ﬂuorouracil (5-FU) and a EGFR–directed monoclonal
antibody, Erbitux (cetuximab) [7–9]. In 2016, the US Food and Drug
Administration (FDA) approved the use of two immune checkpoint
inhibitors (ICIs), nivolumab and pembrolizum, in the treatment on
HNSCC for some patients [10,11].
We have introduced a human 3D myoma disc organotypic model
[12,13] and a gelatinous leiomyoma matrix, Myogel, for in vitro human
cell invasion experiments [14,15]. The hypoxic myoma discs mimic the
TME of solid human tumours, and they contain a variety of non-vital
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cells and soluble invasion-related factors such as lysyl oxidase [16].
Recently, we showed that the invasion eﬃciency of the OTSCC cells
into myoma depends on the amount of tenascin-C and soluble growth
factors and their receptors in the tissue discs [17]. Myogel, on the other
hand, provides a soluble human TME matrix for cancer studies. Com-
pared with the commercial mouse tumour-derived matrix Matrigel®,
Myogel contains e.g. latent and active MMP-2, tenascin-C and collagen
types XII and XIV, which are not present in Matrigel® [14]. A metastatic
niche is required for the survival and growth of metastasizing cancer
cells [18–21]. Formation of this niche is associated with the deposition
and remodelling of extracellular matrix (ECM) and the presence of
hypoxia, growth factors, cytokines and chemokines [22–24]. Interest-
ingly, since the composition of myoma tissue shares the characteristics
of the metastatic niche [14,16] myoma models enable preclinical drug
and chemoradiation testing.
The patient´s response to chemoradiotherapy depends greatly on
the characteristics of the cancer. Therefore, new methods for treatment
testing are needed in order to design personalized therapies. In this
study, we tested the usability and consistency of human TME-mi-
micking tissue methods for analysing the eﬀects of chemoradiation
using commercial OTSCC cell lines. We have previously studied the
feasibility of anti-heparanase aptamers as therapeutic agents against
OTSCC with myoma discs [25], and now we further explored the ef-
fectiveness of these aptamers together with IR in a myoma disc model
and in Myogel. We investigated also the eﬀects of anti-heparanase 1
(HPSE1) antibody, which inhibits heparanase activity [26], and ce-
tuximab (Erbitux), an EGFR inhibitor [27]. Furthermore, we assessed
the short- and long-term eﬀects of IR and invasion on OTSCC cell lines
in myoma organotypic culture and on plastic.
2. Materials and methods
2.1. Cell culture and irradiation
Human tongue squamous cell carcinoma cell lines HSC-3 (JCRB
0623; Osaka National Institute of Health Sciences), SCC-25 (ATCC, CRL
1628) and SAS (JCRB-0260, Osaka National Institute of Health
Sciences) were cultured in 1:1 Dulbecco's Modiﬁed Eagle Medium
(DMEM)/Ham's Nutrient Mixture F-12 (Gibco) supplemented with 10%
heat-inactivated foetal bovine serum (FBS) (Gibco), 100 U/ml peni-
cillin, 100 µg/ml streptomycin, 50 µg/ml ascorbic acid, 250 ng/ml
Amphotericin B and 0.4 µg/ml hydrocortisone (all from Sigma-Aldrich).
All cell lines were cultured at 37 °C in a humidiﬁed atmosphere of 95%
air and 5% CO2 and passaged routinely using trypsin-EDTA (Sigma-
Aldrich).
Cell cultures in diﬀerent experiments were irradiated at doses of 2, 4
and 8 Gy with a Varian Clinac iX linear accelerator (15MV photon
beam) at a dose rate of 4 Gy/min and a ﬁeld size of 30 cm * 30 cm in the
Radiotherapy Unit of Oulu University Hospital. For comparison, an
unirradiated control group (0 Gy) was included in each experiment.
Cells were treated with 0.7mM/10 µg/ml of an antibody against he-
paranase (Anti-HPSE1) [26], 1 µM 1.5M short protected heparanase
aptamer (inverted 3′-base dT5) [28] and 10 µg/ml of Erbitux (Merck
Serono).
Irradiated and invaded HSC-3 cell clones were established from the
bottom of the two wells of a single 24-well Transwell invasion experi-
ment (see later). Cells were cultured 4–10 passages after irradiation,
and in each experiment 0, 2, 4 and 8 Gy clones had equal passage
numbers.
2.2. Myoma disc organotypic culture
Uterine leiomyoma tissues were obtained from routine surgeries of
otherwise healthy donors after informed consent. The study was re-
viewed by the Regional Ethics Committee of the Northern Ostrobothnia
Hospital District (license number 35/2014). HSC-3 cells (700,000 cells)
were added on myoma discs in duplicates and cultured in normal cul-
ture medium containing the indicated concentrations of drugs for 12
days, during which the media and drugs were changed every 3 days
[12,13]. After this, the samples were irradiated as described above.
Finally, all samples were incubated in culture media for 6 days in order
to visualize the possible IR-induced cell invasion in the organotypic
myoma model. At day 18, one of the myoma cultures was ﬁxed in Zinc
ﬁxative, dehydrated, bisected and embedded in paraﬃn. The other
myoma culture was frozen and embedded with Tissue Tek® OCT™
(Sakura).
2.3. Immunohistochemistry and quantiﬁcation of invasion, proliferation,
MMPs and EMT
The paraﬃnized irradiated myoma blocks were sliced in 6 µm sec-
tions with a microtome. The slices were deparaﬃnized and hydrated in
graded alcohol solutions to deionized water. The activity of endogenous
peroxidase was blocked with 0.3% H2O2 in methanol for 30min as the
specimens were prepared for immunohistochemistry of cytokeratin
AE1/AE3, Ki-67, E-cadherin, vimentin, HPSE1, MMP-2 and MMP-9
antibodies. The information of the primary antibodies is shown in Table
S1. The antigen retrieval was conducted by microwaving (T/T Mega)
the specimens in REAL Target Retrieval Solution, pH 6 (citrate buﬀer)
(Dako) or in 10mM Tris/1mM EDTA, pH 9 for 20min. Sections were
blocked with normal serum (Vector Laboratories) in 2% bovine serum
albumin/phosphate-buﬀered saline (BSA/PBS) for 30min and in-
cubated with primary antibodies in an incubator chamber (37 °C) for
another 30min and ﬁnally overnight at 4 °C. Antibody dilutions were
prepared in REAL Antibody Diluent (Dako). Biotinylated secondary
antibody of appropriate species (Vector Laboratories) was applied for
60min, and StreptABComplex/HRP (Dako) in 0.5M NaCl/PBS was
applied for 30min. After each step, the sections were washed twice in
PBS for 10min. The antigen was then visualized by using 3,3′-diami-
nobenzidine (DAB, brown; Vector Laboratories) for 3min. DAB-stained
sections were counterstained with Mayer's haematoxylin and mounted
with xylene. For negative controls, normal serum or IgG of appropriate
species (Dako) was used instead of primary antibody.
Images were acquired from the sections with a DMRB photo mi-
croscope connected to a DFC-480 camera using QWin V3 software (all
from Leica Microsystems). The invasion area and invasion depth were
measured from the pancytokeratin-stained histological sections with
Fiji software as previously described [12,13]. Altogether 24 measure-
ments per test were obtained. Cell proliferation rate was quantiﬁed as a
percentage of Ki-67-positive carcinoma cells among all carcinoma cells
per microscopic ﬁeld at 200 x magniﬁcation. Six ﬁelds per myoma
sample were analysed. To evaluate the possible epithelial-mesenchymal
transition of carcinoma cells, 6 hotspot images with 400 x magniﬁca-
tion were acquired for each sample. For vimentin and HPSE1, the
scoring was assessed by counting the percentage of positive cells/total
cells. With E-cadherin, the intensity of staining was scored with a scale
of 0–3 (0=no staining, 1=low, 2=moderate, 3=high intensity) from
both the surface area and the invasion area. For MMP-2 and − 9,
hotspot images with 200 x magniﬁcation were acquired for the un-ir-
radiated samples and for the samples irradiated with the highest dose
(8 Gy).
2.4. Invasion assay
The ﬁlter of the Transwell-24 plate, pore size 8 µm (Corning) was
coated with 50 µl of Myogel extracellular matrix developed in our la-
boratory (2.4 mg/ml of protein, 0.2% agarose in serum free culture
medium) [14,15] and incubated at room temperature (RT) for 30min.
Next, 500 µl of normal medium containing the indicated amount of
drugs was added in the bottom chambers. Altogether 50000–70000
cells were seeded into the upper chambers in a 200 µl medium, in which
FBS was replaced by 0.5% lactalbumin (Sigma-Aldrich) and contained
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the indicated amount of drugs. The cells were allowed to grow for 21 h,
after which the cells were irradiated as described above. Drugs were
changed in the wells of all plates. For irradiated and invaded cells, only
normal and lactalbumin culture media were used in the assay. Cells
were allowed to invade for 72 h and were then ﬁxed in 4% neutral-
buﬀered Formalin for 1 h and washed once with PBS. Cells were stained
with 1% Toluidine blue-1% Borax for 10min at RT and washed several
times with distilled water. Then, non-invaded cells on the upper surface
of the ﬁlter were carefully removed with a wet cotton swab. Toluidine
blue stain was eluted with 1% SDS and absorbance was measured at
650 nm using a Victor2 Microplate Reader (Perkin Elmer Wallac) [14].
Results represent the average of three to ﬁve independent experiments,
performed in triplicate.
2.5. Proliferation assay
The irradiated and invaded HSC-3 cells were seeded in normal
media on 96-well culture plates at a density of 5000 cells/well in
quadruplicate. The cell proliferation was determined after 24, 48 and
72 h using the Cell Proliferation ELISA BrdU (Roche) according to the
manufacturer's protocol. Absorbance was measured at 450 nm using a
Victor2 Microplate Reader (Perkin Elmer Wallac). Media-only-con-
taining wells were measured as a blank control. The results represent
the average of three separate experiments.
2.6. Clonogenic assay
For analysis of irradiated and invaded HSC-3 cells, 750 or 500 cells
were seeded on a 6-well plate in triplicate and 150 or 100 cells on a 24-
well plate in quadruplicate. For drug treatments, HSC-3 cells were
seeded in normal media on a 24-well culture plate at a density of
150–600 (0–8 Gy)/well in quadruplicate. The cells were allowed to
attach 6 h, after which the drugs were added at the indicated con-
centrations. The next morning, the cells were irradiated as described
above. Drugs/medium were changed after 3 days. Cells were cultured 7
days, ﬁxed with formalin and stained with crystal violet. The results
represent the average of three separate experiments, and the clonogenic
viability of the cells was calculated as previously described [29].
2.7. Immunoblot analysis
The conﬂuent cell ﬂasks were washed twice with PBS and cells were
homogenized with 50mM Tris-HCl pH 7.5, 10mM CaCl2, 150mM
NaCl, 0.05% (v/v) Brij-35 (Sigma-Aldrich) buﬀer including Complete
mini EDTA-free protease inhibitor cocktail (Roche). For analysis of
signalling protein phosphorylation, cells were serum-starved for 24 h
and treated with normal cell culture medium for 1 h. Cells were
homogenized with buﬀer as above, which also contained PhosSTOP™
phosphatase inhibitor tablet (Roche). The cell debris was removed by
centrifugation. The protein concentrations were measured with DC
Protein assay (Bio-Rad), and 20 or 50 µg of soluble proteins were se-
parated under reducing conditions by 8% or 12% SDS-PAGE gels and
transferred to an Immobilon-P membrane (Millipore). The membranes
were blocked with 5% milk powder or for phospho-antibodies 5% BSA
in Tris-buﬀered saline –0.1% Tween 20 and incubated overnight with
mouse anti-E-cadherin (Invitrogen), monoclonal mouse anti-vimentin
(Dako), anti-heparanase 1 (Abcam), HPA1 (Santa Cruz Biotechnology),
EGF receptor, Phospho-EGF receptor (Tyr1068), p44/42 MAPK (Erk1/
2), Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204), Akt, Phospho-
Akt (Ser473) antibodies (all from Cell Signaling Technology) or anti-
beta actin (Abcam) followed by a biotinylated anti-rabbit IgG (DAKO)
or anti-mouse IgG (DAKO) and Vectastain ABC kit (Vector
Laboratories). Immunocomplexes were visualized using a Pierce ECL
Western blotting substrate (Thermo Scientiﬁc) and Luminescent image
analyzer LAS-3000 (Fujiﬁlm). Quantiﬁcation of protein levels was
performed with Fiji software and ß-actin was used to normalize the
results. The results represent the average of two to four independent
experiments, separated two to three times on SDS-PAGE gels.
2.8. Zymography and gelatinase assay
Cells were cultured in 70% conﬂuency in 75 cm2 ﬂasks, washed
with PBS, and Opti-MEM (Gibco) was added. Conditioned medium was
collected 24 h later. Next, 75 µl of conditioned medium was con-
centrated with a speed-vac device, and samples were analysed with
gelatin zymography in 10% SDS-PAGE, casted in the presence of 1mg/
ml ﬂuorescently labelled gelatin (2-methoxy-2,4-diphenyl-3-[2 H] fur-
anone; Fluka). After electrophoresis, SDS was removed by 2.5% Triton
X-100 to renature the gelatinases and gels were incubated in 50mM
Tris-HCl buﬀer, pH 7.8, 150mM NaCl, 5 mM CaCl2, 1 μM ZnCl2 over-
night at 37 °C. The degradation of ﬂuorescent gelatin was visualized
using Molecular imager ChemiDoc XRS+ (Bio-Rad) [30]. The in-
tensities of bands were quantiﬁed with Fiji software. The results re-
present the average of three separate sample sets, each analysed two to
four times. The band intensities were normalized to the cellular soluble
protein concentration.
Gelatinase activity of 70 µl of conditioned medium was assayed with
EnzChek® Gelatinase Assay Kit (Molecular Probes). DQ gelatin
(Molecular Probes) was used with a ﬁnal substrate concentration of
50 µg/ml. Otherwise, the assay was performed according to the man-
ufacturer's protocol. The ﬂuorescence was measured after 3 h incuba-
tion at 485/535 nm using a Victor2 Microplate Reader (Perkin Elmer
Wallac). The results represent the average of three separate sample sets,
each analysed three times. The ﬂuorescence intensities were normal-
ized to the cellular soluble protein concentration.
2.9. Statistical analysis
Calculations were performed with IBM SPSS Statistics version 22
(SPSS, Inc.). Depending on data distribution, the paired samples
Student's T-test and Mann-Whitney U-test were mainly used to de-
termine the statistical diﬀerences. In a few cases in which the dis-
tribution was skewed, the Wilcoxon non-parametric signed-rank test
was used.
3. Results
3.1. Ionizing radiation inhibits HSC3 cell invasion, and addition of an
HPSE1 inhibitor restores this eﬀect in a 3D myoma organotypic model
We have introduced a human 3D myoma organotypic disc model
[12,15] for in vitro invasion experiments. Previously, we showed that
anti-heparanase aptamers inhibited the invasion of a highly aggressive
OTSCC cell line, HSC-3, in myoma discs [25]. In this study, we analysed
the combined eﬀect of aptamers and ionizing radiation (IR) on HSC-3
cell invasion. Cells with an antibody against heparanase (anti-HPSE1)
and the anti-heparanase aptamer 1.5 M short protected (inverted 3′-
base dT5) were ﬁrst cultured for 12 days, after which myomas were
irradiated and further cultured for 6 days. The cell invasion area
(Fig. 1A) and invasion depth (Fig. 1B) were measured from the pan-
cytokeratin AE1/AE3 antibody-stained histological sections. Irradiation
alone signiﬁcantly reduced the invasion area with a dose of 4 Gy
(Fig. 1A) and the invasion depth with doses of 2 and 4 Gy (Fig. 1B).
However, both values increased with a dose of 8 Gy with respect to the
decrease observed with 4 Gy. Treatment with anti-HPSE1 and 1.5M
short protected aptamer signiﬁcantly decreased the invasion area and
invasion depth compared with untreated non-irradiated myomas. This
is in accordance with our previous data showing the eﬀect of these
heparanase inhibitors on invasion [25]. Invasion depth of aptamer-
treated cells decreased with an irradiation dose of 2 Gy compared with
treated non-irradiated cells. Interestingly, the irradiation increased the
invasion area and depth at doses of 4 and 8 Gy, respectively, when the
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samples were treated with anti-HPSE1 and 1.5 short protected apta-
mers. Our data suggest that blocking of HPSE1 activity combined with
IR may induce cell invasion.
3.2. Myogel studies conﬁrm the eﬀect of ionizing radiation combined with
an HPSE1 inhibitor on the invasion of OTSCC cells
We have previously introduced a human gelatinous leiomyoma
matrix named Myogel [14] for in vitro invasion experiments [15]. We
evaluated whether Myogel would be feasible to use in testing che-
moradiation and whether the results would be comparable to the
myoma disc model. To assess the diﬀerences between the two myoma-
based invasion assays and to evaluate the eﬀect of ionizing radiation in
the presence and absence of HPSE1 inhibitors, we used HSC-3 [31,32],
SCC-25 [33] and SAS [34] OTSCC cell lines as models of more and less
invasive OTSCC cell lines. We also included as a control EGFR antibody
Erbitux treatment in addition to anti-HPSE1 antibody and 1.5M short
protected aptamer in a Transwell invasion assay combined with
irradiation (Fig. 2). In the HSC-3 cell line, irradiation alone had only a
slight diminishing eﬀect on invasion (Fig. 2A). The treatments alone
seemed to reduce the invasion compared with untreated, non-irradiated
Fig. 1. Organotypic culture of drug-treated and irradiated HSC-3 cells. HSC-3
cell invasion in myoma discs at day 18 was analysed after treatment with 10 µg/
ml of an antibody against heparanase (Anti-HPSE1) and 1 µM 1.5M short
protected heparanase aptamer and irradiation with doses of 0, 2, 4 and 8 Gy at
day 12. The invasion area (A) and invasion depth (B) were measured from the
pancytokeratin-stained histological sections (n= 24/treatment) with Fiji soft-
ware. P-values were calculated using independent samples #= Student´s T-test,
*= Mann-Whitney U-test or ¶=Wilcoxon non-parametric signed-rank test. One
symbol p < 0.05, Two symbols p < 0.01, Three symbols p < 0.001.
(caption on next page)
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cells. Interestingly, increasing irradiation dose appeared to induce cell
invasion of treated cells compared with the corresponding non-irra-
diated cells, but this was the case only with the highly invasive HSC-3
cell line. This eﬀect was not conﬁrmed in poorly invasive SCC-25 or in
SAS cell lines.
In a less invasive cell line, SCC-25, the irradiation alone signiﬁcantly
decreased the invasion with doses of 4 and 8 Gy (Fig. 2B). The treat-
ments alone did not have signiﬁcant eﬀect on cell invasion compared
with untreated non-irradiated cells, which is consistent with low HPSE1
expression in this cell line (Fig. S1). Irradiation jointly administered
with anti-HPSE1 treatments maintained a constant reduction in cell
invasion compared with the corresponding untreated irradiated cells.
SCC-25 cells did not present the invasion-inducing eﬀect seen in HSC-3
cells. Furthermore, in the SAS cell line irradiation alone also sig-
niﬁcantly decreased invasion dose-dependently (Fig. 2C). In addition,
treatment with anti-HPSE1 and Erbitux signiﬁcantly reduced the in-
vasion of non-irradiated cells compared with untreated non-irradiated
cells. In this case, treatment with anti-HPSE1 combined with irradiation
of 4 Gy signiﬁcantly decreased invasion compared with untreated ir-
radiated cells. Altogether, IR and drug treatment seemed not to have
synergic eﬀects on invasion also in this cell line.
3.3. Ionizing radiation increases expression of MMPs and induces EMT in
myoma model
IR has been shown to upregulate the amount of matrix metallo-
proteinases (MMPs) [6]. We therefore evaluated the eﬀects of irradia-
tion on MMP-2 and MMP-9 expression in HSC-3 cells by im-
munohistochemistry in a myoma model (Fig. 3A and B). We could see
an increase in the number of HSC-3 cells positive for both MMP-2 and
MMP-9 localized in the invasion area of myoma samples irradiated with
8 Gy. In addition, IR may induce pro-survival signalling pathways,
thereby enhancing cell proliferation [6]. In myoma discs, there were no
signiﬁcant changes in the levels of Ki-67 immunoreactivity in 2 Gy ir-
radiated sections compared with non-irradiated ones, indicating no
changes in cell proliferation (Fig. 4A and B). Furthermore, IR is known
to induce epithelial-mesenchymal transition (EMT) in cells, and there-
fore, we also analysed common epithelial marker E-cadherin and me-
senchymal marker vimentin [35] in irradiated myomas by im-
munohistochemistry (Fig. 4C–F). In addition, we analysed HPSE1,
which usually increases with IR (Fig. 4G–J) [36]. Our analysis showed
that the level of E-cadherin was signiﬁcantly decreased (Fig. 4C and D)
and vimentin increased in HSC-3 cells when myomas were irradiated
with 2 Gy (Fig. 4E and F). The level of HPSE1 was increased in 2 Gy
irradiated discs, while cells were counted both from the surface of the
section and from the invasion area and compared with the total cell
number (Fig. 4G–J). Our data suggest that low doses of IR may increase
MMP and HPSE1 expression and initiate EMT in cells cultured in the
myoma model.
3.4. HSC-3 cells, after irradiation and invasion, recover and do not present
any additional changes in proliferation, clonogenic viability or further
invasion capacity
To further determine the eﬀects of irradiation and invasion on the
HSC-3 cells, we established cell clones from previously 0, 2, 4 and 8 Gy
irradiated cells, from the bottom of the Myogel Transwell invasion
assay plates. To perform the assays, two clones were cultured over 4–10
passages, and cells in each experiment had an equal passage number.
Proliferation and clonogenic viability of sub-cultured, previously irra-
diated and invaded cells were tested with BrdU and clonogenic assays.
In these assays, the previously irradiated invaded cells had proliferation
and clonogenic viability comparable to normal HSC-3 cells (Fig. 5A and
B). We also conducted a Myogel Transwell invasion assay, in which no
statistically signiﬁcant diﬀerence was observed (Fig. 5C). Furthermore,
we analysed phosphorylation of EGF receptor and its downstream sig-
nalling protein kinases Akt and Erk1/2 of serum-starved and 1-h serum-
treated cells by immunoblot (Fig. 5D). Previous irradiation and inva-
sion did not induce phosphorylation of EGFR, Akt and Erk1/2 in HSC-3
cells, as there were no signiﬁcant changes observed in the ratio of the
phosphorylated form/total protein (Fig. 5D). Instead, there seemed to
be a trend to lower phosphorylation of Akt and Erk1/2 with doses of 4
and 8 Gy compared with the HSC-3 control. Our data suggest that IR
and invasion do not have long-term eﬀects on proliferation, clonogenic
viability, invasion and activation of signalling pathway proteins in HSC-
3 cells.
3.5. Previous irradiation and invasion of HSC-3 cells results in upregulation
of MMP-2 and MMP-9
As we saw changes in the amount of MMP-2 and MMP-9 staining in
irradiated myomas, supporting the previous ﬁndings with IR and MMPs
[5,6,35] we also studied these MMPs in clones of previously irradiated
and invaded HSC-3 cells. We used zymography and EnzChek assay to
evaluate the MMP amount and gelatinase activities in our previously
irradiated and invaded HSC-3 cells, respectively. In zymography, con-
ditioned media were separated on SDS-PAGE casted in the presence of
ﬂuorescently labelled gelatin, and the sample intensities were normal-
ized to the cellular soluble protein concentration. On zymography gel,
we could see bands corresponding to pro-MMP-9 and pro- and active-
MMP-2 standards (Fig. 6A). Quantiﬁcation of these bands showed that
irradiation dose dependently increased the levels of pro-MMP-2 and
− 9, active-MMP-2 and the total level of these enzymes compared with
control non-irradiated cells (Fig. 6B and C).
Fig. 2. Transwell invasion assay of drug-treated and irradiated OTSCC cell
lines. HSC-3 (A), SCC-25 (B) and SAS (C) cell invasion in Myogel coated
Transwells was analysed after treatment with 10 µg/ml of an antibody against
heparanase (Anti-HPSE1), 1 µM 1.5M short protected heparanase aptamer and
10 µg/ml of Erbitux and irradiation with doses of 0, 2, 4 and 8 Gy. The invaded
cells were stained with Toluidine Blue, the stain was dissolved in 1% SDS so-
lution and the absorbance at 650 nm was measured. The values represent the
average± SD of three to ﬁve separate experiments. P-values were calculated
using Mann-Whitney U-test. * p < 0.05, * * p < 0.01, * ** p < 0.001.
Fig. 3. Immunostaining of MMP-2 and MMP-9 in HSC-3 cells in irradiated or-
ganotypic culture. HSC-3 cells were cultured on top of myoma discs and irra-
diated with doses of 0 and 8 Gy at day 12. The day 18 paraﬃn-embedded
sections were immunostained with MMP-2 (A) and MMP-9 (B) antibodies. Scale
bar 200 µm.
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Fig. 4. Immunostaining of Ki-67, EMT markers and HPSE1 in HSC-3 cells in irradiated organotypic culture. HSC-3 cells were cultured on top of myoma discs and
irradiated with doses of 0 and 2 Gy at day 12. The day 18 paraﬃn-embedded sections were immunostained with the proliferation marker Ki-67 (A), epithelial marker
E-cadherin (C), the mesenchymal marker vimentin (E) and heparanase (HPSE1) (G) antibodies. Cell proliferation rate was quantiﬁed (n= 6 ﬁelds) as a percentage of
Ki-67-positive carcinoma cells among all carcinoma cells per microscopic ﬁeld at 200 x magniﬁcation (B). With E-cadherin, the intensity of staining was scored both
from the surface area and invasion area (n=6 ﬁelds) (D). For vimentin (F) and HPSE1 (H-J), the scoring was assessed by counting the percentage of positive cells/
total cells with 400 x magniﬁcation (n= 6 ﬁelds). P-values were calculated using Mann-Whitney U-test. * p < 0.05, * * p < 0.01, * ** p < 0.001.
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The overall gelatinase activity of the conditioned medium was as-
sayed with the EnzChek® Gelatinase Assay Kit. The ﬂuorescence in-
tensities of samples were normalized to the cellular soluble protein
concentration. The combined gelatin-digesting enzyme activity was not
induced dose-dependently in irradiated invaded cells (Fig. 6D), sug-
gesting that induction could be speciﬁc for MMP-2 and − 9.
To assess EMT in clones of previously irradiated and invaded cells,
we analysed E-cadherin and vimentin by immunoblots. In addition, we
analysed the amount of HPSE1. The immunoblot analysis suggests that
previous irradiation and invasion do not trigger EMT in HSC-3 cells,
while the amounts of E-cadherin and vimentin were not signiﬁcantly
changed (Fig. 7A-B). Furthermore, the amount of HPSE1 was un-
changed in clones of previously irradiated and invaded cells (Fig. 7A
and C).
3.6. Combination of ionizing radiation and anti-HPSE1 aptamers does not
signiﬁcantly alter the clonogenic viability of HSC-3 cells
We recently showed that 1.5 M short heparanase aptamer does not
aﬀect cell viability [25]. We wanted to further investigate how this
treatment combined with irradiation aﬀects OTSCC cells. Therefore, the
eﬀect of anti-HPSE1, 1.5 M short protected heparanase aptamer and
Erbitux in combination with irradiation on the clonogenic viability of
HSC-3 cell line was assessed with a clonogenic assay (Fig. 8). Increasing
numbers of cells were seeded and exposed to diﬀerent doses of irra-
diation combined with drug treatments. Cell colonies were counted
after one-week incubation. Results are presented as surviving fraction
compared with untreated non-irradiated HSC-3 cells. The treatments
alone showed varying degrees of eﬀectiveness. The anti-HPSE1 and
short protected aptamer against HPSE1 alone showed minimal eﬀect, in
accordance with previously published data [25], whereas Erbitux alone
had a diminishing eﬀect of> 50% of clonogenic viability, however this
was not statistically signiﬁcant. Irradiation alone reduced the cell sur-
vival in a dose-dependent increasing manner, as expected. Overall, the
relative survival of HSC-3 treated and irradiated cells, compared with
corresponding untreated irradiated cells, was at the same level. This
suggests that there is no synergistic eﬀect of treatments and irradiation
on cell survival in the conditions used here. There might also be a slight
induction in survival with irradiation at a dose of 4 Gy in each treat-
ment group, which was also conﬁrmed after 72 h in a BrdU assay (data
not shown). Our data suggest that IR does not signiﬁcantly improve the
eﬀectiveness of anti-HPSE1 antibody, 1.5M short protected aptamer
and Erbitux, nor do these have a synergistic eﬀect on cell viability.
4. Discussion
We have previously shown that anti-heparanase aptamers inhibit
the invasion of a highly aggressive OTSCC cell line, HSC-3, in myoma
organotypic culture [25]. In this study, we analysed the eﬀect of io-
nizing radiation (IR) alone, and the combined eﬀects of HPSE1 in-
hibitors and IR on HSC-3 cell proliferation and invasion. We further
analysed the potential use of our human 3D myoma organotypic disc
model [12,13,15] and a gelatinous leiomyoma matrix, Myogel [14,15],
in in vitro chemoradiation studies by comparing these two models. Fi-
nally, we analysed the long-term eﬀect of radiation and invasion by
studying the clones of previously irradiated and invaded HSC-3 cells
collected from a Myogel Transwell model. Our studies presented a
number of important ﬁndings with regard to the eﬀect of IR on cell
invasion, alone or combined with the use of aptamer or antibody-based
HPSE1 inhibitors.
Treatment with both HPSE1 antibody and aptamer had an in-
hibiting eﬀect on the invasion of non-irradiated HSC-3 cells in myoma
discs and Myogel assays, conﬁrming the accurateness of both invasion
models. This is also consistent with our previous results showing that
anti-HPSE1 and 1.5M short aptamer signiﬁcantly decreases the total
invasion area and invasion depth of HSC-3 cells in myoma discs [25].
Our original premise was that IR induces HPSE1 expression [36], and
this may lead to increased invasion capacity, which could be controlled
Fig. 5. Analysis of previously irradiated and invaded HSC-3 cells. The irradiated invaded cells had proliferation (A) and clonogenic viability (B) comparable to
normal HSC-3 cells while tested with BrdU and clonogenic assay, respectively. Irradiation and invasion did not signiﬁcantly induce invasion of HSC-3 cells in Myogel
Transwell invasion assay (C). The values (A-C) represent the average± SD of three to ﬁve separate experiments. In immunoblot analysis (30 µg of soluble protein),
irradiation and invasion seemed not to induce phosphorylation of EGFR, Akt and Erk1/2 in HSC-3, as there were no signiﬁcant changes in the ratio of phosphorylated
form/total protein band (D). The results represent the average of two independent experiments, separated twice on SDS-PAGE gels. In Figure D, representative
immunoblots are shown.
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using HPSE1 inhibitors. Our results with the myoma model conﬁrmed
increased expression of HPSE1, as well as MMP-2 and MMP-9 upon
irradiation. However, in the invasion study, HPSE1 inhibitors were
found to induce HSC-3 invasion when cells were irradiated with doses
of 4 and 8 Gy. This suggests that there may be other pathways reg-
ulating invasion, which are induced due to HPSE1 blocking and sub-
sequent irradiation. Additionally, it was recently shown that knock-
down of HPSE might actually upregulate MMP-2 and MMP-9 expression
[37,38]. This would explain the increase in invasion of HPSE1 antibody
or aptamer treated HSC-3 cells after irradiation found in this study. This
is further supported by our control experiments using two other OTSCC
cell lines, both low in heparanase expression, where use of anti-HPSE
aptamer did not alter the proﬁle of invasion relative to the irradiated,
non-treated cells. Our data further suggest that our human 3D myoma
organotypic model [12,13] and a gelatinous leiomyoma matrix Myogel
[14] are both appropriate for chemoradiation assays, and results with
the tested set of drugs were consistent with both experiments.
As our HPSE1 inhibitor treatments and irradiation seemed to have a
signiﬁcant eﬀect on the HSC-3 cell line, we further analysed the long-
term eﬀects of IR and invasion on this cell line. Therefore, we analysed
cells in irradiated myomas and established irradiated and invaded cell
clones from the Myogel invasion assay. IR is known to trigger several
signal pathways with both pro- and anti-proliferative and migratory
activities. Therefore, the cells that escape the lethal eﬀects of IR may
proliferate more and display enhanced invasive potential [5,6,39]. Our
results showed that irradiation and invasion did not have at least long-
term eﬀects on proliferation, clonogenic viability and invasion of HSC-3
clones. Also in the myoma model, irradiated cells did not show in-
creased proliferation or invasion. IR has been shown to promote the
epidermal growth factor receptor (EGFR) homo- or heterodimerization
that activates downstream pathways, such as mitogen-activated protein
kinase (MAPK) cascade and phosphatidylinositol-4,5-bisphosphate 3-
kinase (PI3K) signalling, which regulate growth, survival, proliferation
and cell migration [6,35,40,41]. Our immunoblot analysis of serum-
starved and 1-h serum-treated cells showed that there were no changes
in activation of EGFR, Erk1/2 or Akt in irradiated and invaded cells.
This ﬁnding is consistent with our proliferation, clonogenic viability
and invasion assays, which also showed no signiﬁcant diﬀerences.
In our immunohistochemical analysis, MMP-2 and MMP-9 amounts
were induced after irradiation in the myoma model. Increased levels of
MMP-2 and MMP-9 have been also previously described in irradiated
cancer cells [5,6,35]. In several studies, the enhanced invasiveness of
irradiated cancer cells has been linked to the increased activity of MMP-
2 and MMP-9 [42–45]. In our analyses of irradiated HSC-3 cells in
myoma at 8 Gy, we saw an increase in both MMP-2 and MMP-9.
However, we could not observe induced invasion, at least not until
4 Gy, although this appeared to revert with a dose of 8 Gy. In clones of
HSC-3 cells previously irradiated and invaded, the level of pro-MMP-2
and pro-MMP-9 and active-MMP-2 increased in a dose-dependent
manner with the radiation previously received by the parent cells.
However, this did not appear to induce activation of ERK and PI3K/Akt
signalling pathways. According to Purushothaman and co-workers,
elevated HPSE1 expression upregulates MMP-9 expression and this
Fig. 6. Zymography and gelatinase assays of irradiated and invaded HSC-3
cells. In gel zymography the conditioned concentrated media of normal and
irradiated and invaded HSC-3 cells were separated on SDS-PAGE. The acryla-
mide gel was embedded with ﬂuorescently labelled gelatin (A). Puriﬁed gela-
tinase standards are shown on the right: pro-MMP-2 (72 kDa), active MMP-2
(62 kDa), pro-MMP-9 (92 kDa) and active MMP-9 (82 kDa). In Figure A, a re-
presentative zymography gel is shown. The amount of proMMP-2 and − 9,
active MMP-2 (B) and total amount of these MMPs (C) in zymography gels was
quantiﬁed with Fiji software, and intensities were normalized to the cellular
soluble protein concentration. The overall gelatinase activity of conditioned
medium was assayed with EnzChek® Gelatinase Assay Kit (D). The ﬂuorescence
intensities were normalized to the cellular soluble protein concentration. The
results represent the average± SD of three separate sample sets each analysed
three to four times. P-values were calculated using Mann-Whitney U-test.
* p < 0.05, * * p < 0.01, * ** p < 0.001.
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stimulation depends on the ERK signalling pathway [46]. On the other
hand, IR has been suggested to regulate MMP-2 and MMP-9 expression
through the PI3K/Akt signalling pathway [44,45], and IR has been
shown to increase HPSE1 expression in PANC-1 cells [36]. It is there-
fore possible that this is all part of the same pathway, where IR aug-
ments HPSE1 expression, which in turn regulates MMP-2 and MMP-9
expression. The HSC-3 cell line has been shown to have intense HPSE1
mRNA expression and enzyme activity [47,48]. Indeed, our analysis of
HPSE1-positive cells in the myoma model demonstrated an increase in
HPSE1 expression during irradiation, as well as MMP-2 and MMP-9
expression, suggesting that HPSE1-mediated signalling of MMP-9 up-
regulation might be active in this model. Interestingly, although HPSE1
overexpression ceased in the clones of the previously irradiated and
invading HSC-3 cells, these maintained increased MMP-2 and MMP-9
expression. It is possible that MMP-2 and MMP-9 expression is turned
on even if the signalling pathways are no longer activated.
Epithelial-mesenchymal transition (EMT) is a process in which the
normal epithelial cells gain pro-invasive characteristics, such as loss of
attachment to each other and to the basement membrane, and gain
enhanced motility [49]. IR has been shown to induce EMT [6,35,50],
Fig. 7. Immunoblot analysis of EMT markers and HPSE1 in irradiated and in-
vaded HSC-3 cells. Normal and irradiated and invaded HSC-3 cell homogenates
(50 µg of soluble protein) were separated on SDS-PAGE gels. Amounts of epi-
thelial marker E-cadherin, the mesenchymal marker vimentin and heparanase
(HPSE1) were analysed with immunoblots (A). In Figure A, representative
immunoblots are shown. Beta-actin was used as a control to normalize the
quantities of E-cadherin (B), vimentin (C) and HPSE1 (D). The results represent
average± SD of four independent experiments, separated three times on SDS-
PAGE gels.
Fig. 8. Clonogenic viability of drug treated and irradiated HSC-3 cell line. Cells
were treated with 10 µg/ml of an antibody against heparanase (Anti-HPSE1),
1 µM 1.5M short protected heparanase aptamer and 10 µg/ml of Erbitux and
irradiated with doses of 0, 2, 4 or 8 Gy. Cell colonies were cultured 7 days, ﬁxed
and stained with crystal violet (A). In ﬁgure A, representative 24-wells irra-
diated with 0 and 8 Gy are shown. The clonogenic viability was presented as the
surviving fraction relative to untreated non-irradiated HSC-3 cells (B). The re-
sults represent the average of three separate experiments.
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which is characterized by a progressive loss of epithelial morphology
and markers, such as E-cadherin, and gain of mesenchymal markers like
vimentin [51]. We have recently shown that the myoma organotypic
model initiates expression of vimentin in HSC-3 cells [12]. In this study,
we report that IR further induces EMT in the myoma model, but loss of
E-cadherin and appearance of vimentin were not seen when the pre-
viously irradiated invading cells were subsequently cultured on plastic.
This could highlight the relevance of the environment, as plastic does
not oﬀer a realistic surrounding for the cancer cells. The myoma model
provides a more genuine, 3D environment in which the cancer cells are
in contact not only with each other but also with the surrounding
matrix.
Finally, we analysed the clonogenic viability of the cells in the
presence of HPSE1 inhibitors and increasing doses of IR. In accordance
with our previously published data, anti-HPSE aptamer has little or no
eﬀect on cell viability, conﬁrming that any observed inhibitory eﬀects
on invasion are due to HPSE1 inhibition and not due to a cytotoxic
eﬀect. Furthermore, we labelled the 1.5 short protected aptamer with 5′
Alexa Fluor 546 label and followed them in a ﬂuorescence microscopy
experiment, where we saw that the aptamer was taken successfully into
the cells (unpublished data). We found no signiﬁcant diﬀerence be-
tween the use of IR alone and in combination with HPSE1 inhibitors,
with perhaps a small exception regarding increased clonogenic viability
at 4 Gy. The most interesting ﬁnding is the inverse correlation observed
between survival and invasiveness, expressed mainly in cells treated
with HPSE1 inhibitors and irradiated at 8 Gy. While at 8 Gy, only a
fraction of the cells remain alive (Fig. 8), there is an increased invasive
activity associated with this population at this dose of irradiation
(Figs. 1A and 2A). This result might suggest, in fact, that there is a
phenotype change in survivors after HPSE1 inhibitor treatment and
irradiation that exacerbates the invasion capacity of these cells.
5. Conclusions
We found that human uterine leiomyoma-based ECM models,
myoma discs and Myogel, are reliable methods for testing the eﬀects of
chemoradiation treatment on human carcinoma cells. Our data suggest
that blocking of HPSE1 activity combined with IR may induce cell in-
vasion. In addition, we showed that irradiation had a lasting eﬀect on
induction of MMP-2 and MMP-9.
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